Synapse - Bianca Santomasso

Results (87)

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Journal Article

Cohen, A. D.; Parekh, S.; Santomasso, B. D.; Pérez-Larraya, J. G.; van de Donk, N. W. C. J.; Arnulf, B.; Mateos, M. V.; Lendvai, N.; Jackson, C. C.; De Braganca, K. C.; more...
Blood Cancer Journal (2022)

Fulltext@MSK | Save

The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors

Meeting Abstract

Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline

Guidelines

Santomasso, B. D.; Nastoupil, L. J.; Adkins, S.; Lacchetti, C.; Schneider, B. J.; Anadkat, M.; Atkins, M. B.; Brassil, K. J.; Caterino, J. M.; Chau, I.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update

Guidelines

Schneider, B. J.; Naidoo, J.; Santomasso, B. D.; Lacchetti, C.; Adkins, S.; Anadkat, M.; Atkins, M. B.; Brassil, K. J.; Caterino, J. M.; Chau, I.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2

Meeting Abstract

Einsele, H.; Parekh, S. S.; Madduri, D.; Santomasso, B.; De Larraya, J. G. P.; van de Donk, N. W. C. J.; Arnulf, B.; Mateos, M. V.; De Braganca, K. C.; Varsos, H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events

Meeting Abstract

Luo, J.; Beattie, J.; Fuentes, P.; Rizvi, H.; Egger, J. V.; Kern, J.; Leung, D. Y. M.; Lacouture, M. E.; Kris, M. G.; Gambarin, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with multiple myeloma

Meeting Abstract

Einsele, H.; Parekh, S.; Madduri, D.; Santomasso, B.; Pérez-Larraya, J. G.; van de Donk, N. W.C.J.; Arnulf, B.; Mateos, M. V.; De Braganca, K. C.; Varsos, H.; more...
Clinical Lymphoma, Myeloma and Leukemia (2021)

Fulltext@MSK | Save

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report

Journal Article

Wolff, D.; Radojcic, V.; Lafyatis, R.; Cinar, R.; Rosenstein, R. K.; Cowen, E. W.; Cheng, G. S.; Sheshadri, A.; Bergeron, A.; Williams, K. M.; more...
Transplantation and Cellular Therapy (2021)

Fulltext@MSK | Save

Incidence, mitigation, and management of neurologic adverse events in the CARTITUDE-2 study of patients with multiple myeloma treated with ciltacabtagene autoleucel (cilta-cel)